IM Cannabis Corp. is proposing a reverse merger with Israeli biotechnology firm Kadimastem in which it would spin out – and potentially sell – its existing medical marijuana operations in Israel and Germany.
Israel’s IMC looks to spin out, sell c…
IM Cannabis Corp.
Israel’s IMC looks to spin out, sell cannabis unit in pivot to biotech sector
IM Cannabis Corp. is proposing a reverse merger with Israeli biotechnology firm Kadimastem in which it would spin out – and potentially sell – its existing medical marijuana operations in Israel and Germany.
Israel’s IMC looks to spin out, sell c…